XML 45 R30.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock option and award plan: (Tables)
12 Months Ended
Dec. 31, 2024
Stock option and award plan:  
Schedule of assumptions used for determining the fair value of options granted

Years Ended

 

December 31, 

Black-Scholes Assumptions

    

2024

    

2023

    

2022

 

Dividend yield

 

6.0

%  

5.8

%  

5.9

%

Expected volatility

 

34.9

%  

33.4

%  

33.1

%

Risk-free interest rate

 

4.1

%  

3.8

%  

3.0

%

Expected life of the option term (in years)

 

4.1

4.1

4.1

Schedule of stock option activity

    

Number of

    

Weighted-Average

    

Options

    

Exercise Price

Outstanding at December 31, 2023

 

198,775

$

61.97

Granted

 

120,784

$

70.21

Cancelled and expired

 

(62,138)

$

66.05

Exercised—intrinsic value $0.5 million; cash received $1.2 million

 

(36,465)

$

60.45

Outstanding at December 31, 2024—$2.7 million intrinsic value and 7.7 years weighted-average remaining contractual term

 

220,956

$

65.58

Exercisable at December 31, 2024—$1.5 million intrinsic value and 6.1 years weighted-average remaining contractual term

 

95,330

$

62.15

Expected to vest—$2.3 million intrinsic value and 7.4 years weighted-average remaining contractual term

 

183,864

$

64.94

Schedule of non-vested restricted stock awards

Weighted-Average

Grant Date

Non-vested awards

    

Shares

    

Fair Value

Non-vested at December 31, 2023

 

1,261,623

$

62.89

Granted

 

672,098

$

68.58

Vested

 

(315,559)

$

66.11

Forfeited

 

(128,885)

$

66.66

Non-vested at December 31, 2024

 

1,489,277

$

64.45

    

Years Ended

 

December 31,

Additional Award Plan Information – Related to Stock Options & Restricted Stock (thousands)

 

2024

   

2023

    

2022

Equity-based compensation expense

$

25,738

$

26,924

$

24,439

Income tax benefit related to stock options and restricted stock

 

2,469

 

3,307

 

2,489

Capitalized compensation expense related to stock options and restricted stock

 

3,100

 

3,541

 

2,277

Intrinsic value of stock options exercised

 

573

 

456

 

305

Fair value of shares of restricted stock vested

 

22,489

 

30,113

 

25,792